Tempest Ebt Per Ebit from 2010 to 2024

TPST Stock  USD 1.10  0.01  0.92%   
Tempest Therapeutics Ebt Per Ebit yearly trend continues to be comparatively stable with very little volatility. Ebt Per Ebit is likely to outpace its year average in 2024. From the period from 2010 to 2024, Tempest Therapeutics Ebt Per Ebit quarterly data regression had r-value of  0.07 and coefficient of variation of  63.53. View All Fundamentals
 
Ebt Per Ebit  
First Reported
2010-12-31
Previous Quarter
1.01145523
Current Value
1.42
Quarterly Volatility
0.80135973
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tempest Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tempest Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 361.9 K, Interest Expense of 1.5 M or Selling General Administrative of 15.4 M, as well as many indicators such as Price To Sales Ratio of 1.36, Dividend Yield of 0.0 or PTB Ratio of 3.14. Tempest financial statements analysis is a perfect complement when working with Tempest Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Tempest Therapeutics Correlation against competitors.
For more information on how to buy Tempest Stock please use our How to Invest in Tempest Therapeutics guide.

Latest Tempest Therapeutics' Ebt Per Ebit Growth Pattern

Below is the plot of the Ebt Per Ebit of Tempest Therapeutics over the last few years. It is Tempest Therapeutics' Ebt Per Ebit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tempest Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Ebt Per Ebit10 Years Trend
Very volatile
   Ebt Per Ebit   
       Timeline  

Tempest Ebt Per Ebit Regression Statistics

Arithmetic Mean1.26
Geometric Mean1.15
Coefficient Of Variation63.53
Mean Deviation0.40
Median1.02
Standard Deviation0.80
Sample Variance0.64
Range3.1481
R-Value0.07
Mean Square Error0.69
R-Squared0
Significance0.82
Slope0.01
Total Sum of Squares8.99

Tempest Ebt Per Ebit History

2024 1.42
2023 1.01
2021 1.05
2019 0.98
2018 1.18
2017 4.13
2016 1.09

About Tempest Therapeutics Financial Statements

Tempest Therapeutics shareholders use historical fundamental indicators, such as Ebt Per Ebit, to determine how well the company is positioned to perform in the future. Although Tempest Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Tempest Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Tempest Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Ebt Per Ebit 1.01  1.42 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Tempest Stock Analysis

When running Tempest Therapeutics' price analysis, check to measure Tempest Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tempest Therapeutics is operating at the current time. Most of Tempest Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tempest Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tempest Therapeutics' price. Additionally, you may evaluate how the addition of Tempest Therapeutics to your portfolios can decrease your overall portfolio volatility.